CALR and neoplasm: Calreticulin acts as an “eat me” signal for phagocytes, increasing the processing and presentation of tumor-associated and tumor-specific antigens, whereas cell surface HSP70 and HSP90 expression plays a major role in the cross-presentation of tumor-derived antigenic peptides, leading to specific T-cell responses [38,39].